Inhibitory Control Test for the Diagnosis of Minimal Hepatic Encephalopathy

Size: px
Start display at page:

Download "Inhibitory Control Test for the Diagnosis of Minimal Hepatic Encephalopathy"

Transcription

1 GASTROENTEROLOGY 2008;135: Inhibitory Control Test for the Diagnosis of Minimal Hepatic Encephalopathy JASMOHAN S. BAJAJ,* MUHAMMAD HAFEEZULLAH, JOSE FRANCO, RAJIV R. VARMA, RAYMOND G. HOFFMANN, JOSHUA F. KNOX, DARRELL HISCHKE, THOMAS A. HAMMEKE, STEVEN D. PINKERTON, and KIA SAEIAN *Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia; Division of Gastroenterology and Hepatology, Department of Population Health/Division of Biostatistics, Division of Neuropsychology, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin See editorial on page Background & Aims: Minimal hepatic encephalopathy (MHE) is difficult to diagnose. The Inhibitory Control Test (ICT) measures response inhibition and has diagnosed MHE with 90% sensitivity and specificity in a selected population; high lure and low target rates indicated poor ICT performance. We studied the reliability and validity of ICT for MHE diagnosis. Methods: ICT was compared with a psychometric battery (standard psychometric tests [SPT]) for MHE diagnosis and overt hepatic encephalopathy (OHE) prediction. ICT was administered twice for test-retest reliability, before/after transvenous intrahepatic portosystemic shunting (TIPS), and before/after yogurt treatment. The time taken by 2 medical assistants (MA) to administer ICT was recorded and compared with that of a psychologist for cost analysis. Results: One hundred thirty-six cirrhotic patients and 116 age/education-matched controls were studied. ICT (>5 lures) had 88% sensitivity for MHE diagnosis with area under the curve for receiver operating characteristic. MHE-positive patients had significantly higher ICT lures (11 vs 4, respectively, P.0001) and lower targets (92% vs 97%, respectively, P.0001) compared with MHEnegative patients. The test/retest reliability for ICT lures (n 50, r 0.90, P.0001) was high. ICT and SPT were equivalent in predicting OHE (21%). ICT lures significantly worsened after TIPS (n 10; 5 vs 9, respectively; P.02) and improved after yogurt supplementation (n 18, 10 vs 5, respectively; P.002). The MAs were successfully trained to administer ICT; the time required for test administration and the associated costs were smaller for ICT than for SPT. Conclusions: ICT is a sensitive, reliable, and valid test for MHE diagnosis that can be administered inexpensively by MAs. Minimal hepatic encephalopathy (MHE) is a neurocognitive complication of cirrhosis, which has been reported in up to 80% of tested patients. 1 3 It is associated with increased progression to overt hepatic encephalopathy (OHE), diminished quality of life, and driving impairment as well as a high risk of traffic accidents. 4 8 MHE results in a specific spectrum of cognitive deficits, especially in the domains of attention, vigilance, response inhibition, and executive function Psychometric tests for MHE diagnosis specifically assess these cognitive domains. 12 The difficulty in applying these psychometric tests in the United States is the need for psychologic expertise for clinical administration and interpretation, the expensive and copyrighted testing procedures, and the lack of reimbursement by insurance companies. These issues were highlighted in a recent survey of the American Association for the Study of Liver Diseases (AASLD) in which, although most respondents believed MHE to be a serious problem that required testing, only a minority reported doing so. 13 Most respondents believed that a simple test that could be administered by clinic personnel would increase their testing rates. 13 The Inhibitory Control Test (ICT) is a computerized test of attention and response inhibition that has been used to characterize attention deficit disorder, schizophrenia, and traumatic brain injury. 10,14 17 ICT is similar to the continuous performance test and consists of presentation of several letters at 500-ms intervals. 18 Interspersed within these letters are the letters X and Y. The subject is instructed to respond to every X and Y during the initial part of the training run, which establishes the prepotent response. In the latter part of the training run, the subject is instructed only to respond when X and Y are alternating (called targets) and to inhibit from responding when X and Y are not alternating (called lures). After the training run, 6 test runs, which last approximately 2 minutes each, are administered with a total of 40 lures, 212 targets, and 1728 random letters in be- Abbreviations used in this paper: MHE, cirrhotic patients with minimal hepatic encephalopathy; MHE, cirrhotic patients without minimal hepatic encephalopathy; OHE, overt hepatic encephalopathy; SPT, standard psychometric tests; ICT, inhibitory control test; NCT-A, number connection test; DST, digit symbol; BDT, block design test; TIPS, intrahepatic portosystemic shunting by the AGA Institute /08/$34.00 doi: /j.gastro

2 1592 BAJAJ ET AL GASTROENTEROLOGY Vol. 135, No. 5 tween. At the end of the test, the lure and target response rates, lures, and target reaction times are automatically calculated. Lower lure response, higher target response, and shorter lure and target reaction times indicate good psychometric performance. ICT has been used for the diagnosis of MHE by our group in 50 nonalcoholic cirrhotic patients compared with 50 age- and education-matched controls with 90% sensitivity and specificity. 19 ICT was similar to the battery of standard psychometric tests (SPT) for prediction of OHE development and had good test-retest reliability. This was an initial report in highly selected and motivated patients and excluded all patients with an alcoholic etiology of cirrhosis. Furthermore, external validation was not performed in that initial study. 19 The aims of this present study were to (1) validate the ICT for the diagnosis of MHE in cirrhotic patients by comparing them with age- and education-matched controls; (2) assess its test-retest reliability; (3) determine its external validity by studying ICT before and after transvenous intrahepatic portosystemic shunting (TIPS), before and after yogurt supplementation, and its ability to predict onset of OHE; and (4) estimate the time and cost required for previously untrained medical assistants to administer the test in the hepatology clinic. Patients and Methods Outpatients with cirrhosis were recruited between September 2004 and December 2007 through clinical referral. Patients between ages 18 and 65 years, without current psychoactive drug use, not on OHE treatments, without history of OHE, and without alcohol use within 3 months were included. MHE Definition and SPT SPT battery for this study was the Number Connection Test-A (NCT-A) and 2 subtests of the Wechsler s Adult Intelligence Scale-III: Digit Symbol Test (DST) and Block Design (BDT) tests. 20 MHE was defined as a performance impaired 2 standard deviations beyond that of the age/education-matched controls on any test. This is modified from the Working Group on Hepatic Encephalopathy recommendation, which has previously been used to diagnose MHE and predict OHE and driving impairment in our population. 12,19,21 The study was divided into the following parts: (1) Cross-sectional study of SPT vs ICT for MHE diagnosis. (2) Test-retest reliability of SPT and ICT. (3) Follow-up of cirrhotic patients to detect OHE development. (4) External validity: (a) study change in ICT and SPT after TIPS placement and (b) study change in ICT and SPT after probiotic yogurt supplementation. (5) Time and cost analysis of ICT administration in hepatology clinics. For study parts 1, 2, and 3, a total of 256 patients without OHE or without current OHE therapy were considered for recruitment; 65 refused to participate, 33 had concurrent psychoactive drug use (antianxiety, antipsychotics, antiepileptics, and interferon), and 23 had consumed alcohol within 3 months. As a result, 135 cirrhotic patients were included in the study. Age- and educational status-matched healthy controls were recruited from the community through advertisements. Written informed consent was obtained from each participant. MHE Diagnosis With ICT vs SPT All patients and controls were administered the SPT and ICT during the same sitting under the supervision of a psychologist who was blinded to the nature of the participants. Parameters recorded were NCT-A completion time in seconds, raw score of DST and BDT, ICT lure and target response rates, and ICT lure and target reaction times. Control and cirrhotic groups were compared with respect to demographics and psychometric test results. Correlation between age with individual ICT and SPT results were performed for both groups. Cirrhotic patients were divided into those with MHE (MHE ) and those without MHE (MHE ) using SPT as the gold standard. Sensitivity and specificity of diagnosis of MHE using ICT data were compared using the receiver operating characteristic and area under the curve and logistic regression. A subgroup analysis of psychometric tests was performed within the cirrhotic group for hepatitis C-positive cirrhotic patients, those with alcoholic cirrhosis, and those with both. Test-Retest Reliability A randomly selected group of controls and cirrhotic patients underwent SPT and ICT twice at least 30 days apart to gauge the test-retest reliability. There was no change in the clinical status (Child Pugh score), addition of psychoactive medications, or development of new complications of cirrhosis (variceal bleeding, ascites, and others) in between the 2 testing times. Spearman rank correlation was used to correlate the NCT-A, BDT, DST, and ICT lure and target response of the first and second administration. Follow-Up to Evaluate OHE Development Patients who were enrolled in the cross-sectional study were followed up as a matter of clinical practice by the primary hepatologists for the detection of OHE. OHE was diagnosed when the patient was started on therapy and the precipitating factor was recorded. Development of OHE was compared between patients with MHE according to SPT vs ICT. Patients with discordant or concordant results on initial testing were compared. External Validity SPT and ICT changes after TIPS placement. Consecutive outpatient cirrhotic patients who underwent elective TIPS placement were studied with SPT and ICT

3 November 2008 DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY 1593 at least 30 days prior to and 30 days post-tips. Patients already on OHE therapy, those with psychoactive medications, and those who underwent emergent TIPS were excluded from this study. There was no primary prophylaxis protocol against OHE post-tips in place. Patients were reexamined post-tips for OHE development and chart review to evaluate for OHE development before that visit was performed. TIPS stent characteristics and reduction in hepatic portal venous pressure gradient were recorded. ICT and SPT parameters before and after TIPS were compared using paired t tests. SPT and ICT changes after probiotic yogurt supplementation in a randomized, controlled trial. Consecutive MHE patients were enrolled for a randomized, controlled trial of probiotic yogurt for MHE treatment. 22 All patients fulfilled the overall inclusion and exclusion criteria of the cross-sectional study and underwent SPT and ICT at baseline. Patients were randomized in a 2:1 ratio into the yogurt and the no-treatment group and were followed for 60 days, at the end of which SPT and ICT were both repeated at the same sitting by a scorer blinded to the randomization scheme. Paired t test within groups and 2 sample t tests were used to compare continuous variables, and Fisher exact test was used to compare binary variables between groups. Time and Cost Analysis of ICT Administration in the Clinic To assess the time and costs associated with ICT administration in a real-world clinic setting, 2 medical assistants (MAs; one 31 years old and other 64 years old; both women) were trained to administer ICT on a laptop computer in the hepatology clinic. After training on the computer for 30 minutes each, they were asked to administer the test to the principal investigator (J.S.B.) to evaluate their ability to administer this test. They then administered the test to 10 subjects each (5 cirrhotic patients and 5 controls) to ensure proficiency in test administration. After adequate training of the MAs, the time required for administration of ICT was recorded for the next 20 patients. The time required for administration of the standard psychometric battery by the psychologist was also determined for the same patients. Current procedural terminology codes for a MA assessment (E and M 1; 99211) and for neuropsychologic testing by a psychologist (96118) were used to estimate third-party charges and Medicare reimbursement. 23 Fixed costs for the copyrighted Wechsler s Adult Intelligence Scale-III instrument and materials and for computer time for ICT were excluded from the analyses because these costs are likely to be negligible when averaged over large numbers of test administrations. Results Cross-Sectional Study of the SPT and ICT for Diagnosing MHE Within the cirrhotic patients, there were 8 patients between 18 and 35 years, 67 between 36 and 55 years, and 48 patients between 56 and 65 years of age. Of the 116 controls, 23 were between 18 and 35 years, 66 between 36 and 55 years, and 27 between 56 and 65 years of age. Control and cirrhosis group results and MHE definition. There was no significant difference in demographics (Table 1). The cirrhotic group was significantly impaired with respect to SPT performance compared with controls. A patient with cirrhosis was considered to be MHE if any of the following conditions were met: NCT-A 35 seconds, BDT raw score 28, or DST raw score 66. Similarly, there was a significantly higher ICT Table 1. Comparison Between Controls and Patients With Cirrhosis Controls (n 116) Cirrhotic patients (n 135) P values Age (y) Sex (M/F) 63/53 72/63.88 Education (y) Etiology of cirrhosis (HCV/alcohol/HCV alcohol/others) 45/19/13/42 NCT-A (seconds) DST (raw score) BDT (raw score) Response to ICT lures (number out of 40) Response to ICT targets (percentage responded to) ICT lure reaction time (milliseconds) ICT target reaction time (milliseconds) NOTE. Controls were age- and educational status-matched with cirrhotic patients; sex distribution was similar between the groups. Others within the cirrhotic group included 14 patients with nonalcoholic steatohepatitis, 11 with primary sclerosing cholangitis, 9 with primary biliary cirrhosis, and the remainder with cryptogenic cirrhosis. There was a significantly impaired performance in each SPT test in cirrhotic patients compared with controls. A significantly worse ICT psychometric performance, ie, higher lure response rate, lower target response rate, and higher lure and target response time, was observed. HCV, hepatitis C only; SPT, standard psychometric tests; ICT, Inhibitory Control Test; NCT-A, Number Connection Test; DST, Digit Symbol Test; BDT, Block Design Test.

4 1594 BAJAJ ET AL GASTROENTEROLOGY Vol. 135, No. 5 Table 2. Comparison Between Patients With Cirrhosis With and Without Minimal Hepatic Encephalopathy MHE (n 87) MHE (n 48) P value Age (y) Sex (M/F) 46/41 26/22.89 Education (y) Child Pugh score distribution 58/26/3 41/7/0.05 (A/B/C) Chronic hepatitis C (%) 41 (47) 17 (35).19 Alcoholic cirrhosis (%) 22 (25) 10 (21).56 NCT-A (seconds) DST (raw score) BDT (raw score) Response to ICT lures (number out of 40) Response to ICT targets (percentage responded to) ICT lure reaction time (milliseconds) ICT target reaction time (milliseconds) NOTE. A cirrhotic patient was considered to be MHE if any of the following conditions were met: NCT-A 35 seconds, BDT raw score 28, or DST raw score 66. There was no significant difference in age, educational status, sex distribution, Child Pugh score, chronic hepatitis C, and alcoholic cirrhosis prevalence between cirrhotic patients with and without MHE. There was a significantly impaired performance in each SPT test in MHE cirrhotic patients compared with MHE cirrhotic patients. A significantly worse ICT psychometric performance, ie, higher lure response rate, lower target response rate, and higher lure and target response time, was observed. MHE, cirrhotic patients with minimal hepatic encephalopathy; MHE, cirrhotic patients without minimal hepatic encephalopathy; SPT, standard psychometric tests; ICT, Inhibitory Control Test; NCT-A, Number Connection Test; DST, Digit Symbol Test; BDT, Block Design Test. The MHE group had a significantly higher rate of lure response and longer lure and target reaction times. MHE patients also demonstrated a significantly lower target response compared with MHE (Table 2) patients. Sensitivity and specificity of ICT using SPT as the gold standard. A cut off of 5 lures per person was used to diagnose MHE based on receiver operating characteristic analysis and our prior study. 19 Of the 87 MHE patients by SPT, 76 had 5 lures, and 11 did not. Of the 48 MHE patients by SPT, 37 had 5 lures, and 11 had 5 lures. Sensitivity was 87%, and specificity was 77% for the diagnosis of MHE using ICT lure threshold of 5 lures (Figure 1A). The receiver operating characteristic curve had an area under the curve of for MHE diagnosis using lures (Figure 1B). lure response, a significantly lower ICT target response, and a longer target reaction time in the cirrhotic group compared with controls. Comparison within the cirrhotic group. Using the a priori definition, 87 patients were considered to be MHE, and the remaining 48 were MHE (Table 2). Therefore, 48 patients were not impaired in any test. Of the 87 MHE patients, 25 were impaired on all 3 tests, 24 patients on 2 tests, and 38 patients on 1 psychometric test. A significant positive correlation between number of impaired tests on the SPT and lure response (r 0.51, P.0001) and a significant negative correlation of targets with number of impaired tests on SPT (r 0.39, P.0001) was observed. There was also a significant negative correlation between ICT lures and targets (r 0.37, P.0001). There was no significant difference in demographics, prevalence of hepatitis C, or alcoholic etiology of cirrhosis between MHE and MHE groups. A borderline statistically significant predominance of Child Pugh B and C class cirrhotic patients in the MHE group was observed (P.05). Figure 1. (A) The individual value plot of lures in cirrhotic patients with and without MHE shows 88% sensitivity and 77% specificity for the diagnosis of MHE using a cut off of 5 lures and above. SPT was used as the gold standard for the diagnosis of MHE. The total number of lures in the ICT is 40. MHE, minimal hepatic encephalopathy; SPT, standard psychometric battery. (B) The receiver operating characteristic curve for the ICT lure response for the diagnosis of MHE using SPT as a gold standard showed that an area under the curve was There was no significant contribution of ICT targets, lure, and target reaction time to this area under the curve on logistic regression. MHE, minimal hepatic encephalopathy; SPT, standard psychometric battery.

5 November 2008 DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY 1595 Table 3. Comparison Between Patients With Cirrhosis With and Without Chronic Hepatitis C as the Etiology of Cirrhosis HCV positive (n 58) HCV negative (n 77) P value Age (y) NCT-A (seconds) DST (raw score) BDT (raw score) Response to ICT lures (number out of 40) Response to ICT targets (%) ICT lure reaction time (milliseconds) ICT target reaction time (milliseconds) NOTE. There was no significant difference in age, individual SPT performance, and all aspects of ICT performance, ie, lure response rate, target response rate, and lure and target reaction times, between cirrhotic patients with and without HCV infection (included 13 patients with HCV and alcohol). SPT, standard psychometric tests; ICT, Inhibitory Control Test; NCT-A, Number Connection Test; DST, Digit Symbol Test; BDT, Block Design Test. Correlation between SPT and ICT parameters within the cirrhotic group. There was a significant correlation between ICT lures and targets with SPT performance. ICT lures were positively correlated with NCT-A performance (r 0.41, P.0001) and negatively correlated with BDT (r 0.40, P.0001) and DST (r 0.36, P.0001). ICT targets were significantly negatively correlated with NCT-A (r 0.29, P.001) and positively correlated with BDT (r 0.29, P.001) and DST (r 0.41, P.001). Correlation of age with SPT and ICT results. There was a significant positive correlation between age and NCT-A (r 0.425, P.0001) in controls. BDT (r 0.437, P.0001) and DST (r 0.417, P.0001) demonstrated a corresponding significant negative correlation with age in controls. ICT lures were not significantly correlated with age in controls (r 0.121, P.23). Similar to the control group, there was a significant negative correlation between BDT (r 0.231, P.01) and age in cirrhotic patients. However, there was no significant correlation in the cirrhotic group between NCT-A (r 0.204, P.79) and DST (r 0.13, P.15) scores and age. ICT lures continued to demonstrate no significant correlation with age in the cirrhotic patients (r 0.06, P.51). Because some of the metrics showed age effects, cirrhotic patients were age matched to controls. Hepatitis C, alcoholic cirrhosis, and both subgroup analysis. Within the cirrhotic patients, 58 patients had chronic hepatitis C, and 77 did not. There was no statistically significant difference in SPT or ICT parameters between those with or without hepatitis C groups (Table 3). Similarly, no significant difference in ICT or SPT parameters was observed between those with an alcoholic etiology of cirrhosis compared with cirrhotic patients without alcohol as the etiology (Table 4). Thirteen patients had both alcohol- and chronic hepatitis C-associated cirrhosis; the performance on SPT (NCT-A: 36 8 seconds, BDT: 33 9, DST: 57 12) and ICT (targets 92 7 and lures 7 7) were statistically similar to patients with chronic hepatitis C and those with alcoholic cirrhosis. Test-Retest Reliability Results A randomly selected group of 20 controls and 30 cirrhotic patients from the patients enrolled above were administered the SPT and ICT days apart. No change in the clinical status of the patients and controls was observed in the interim. The 30 cirrhotic patients included 21 with hepatitis C, 5 with alcoholic cirrhosis, 3 with cryptogenic cirrhosis, and 1 with primary biliary cirrhosis; all were Child Pugh class A. Both ICT and SPT parameters had a strong test-retest correlation in cirrhotic patients as well as controls (Table 5). None of the test-retest correlations differed significantly between the controls and the cirrhotic patients. Table 4. Comparison Between Patients With Cirrhosis With and Without Alcohol as the Etiology of Cirrhosis Alcoholic etiology (n 32) Nonalcoholic etiology (n 103) P value Age (y) NCT-A (seconds) DST (raw score) BDT (raw score) Response to ICT lures (number out of 40) Response to ICT targets (%) ICT lure reaction time (milliseconds) ICT target reaction time (milliseconds) NOTE. All included patients had not consumed alcohol within 3 months before the study. There was no significant difference in age, individual SPT performance, and all aspects of ICT performance, ie, lure response rate, target response rate, and lure and target reaction times between cirrhotic patients with and without history of alcoholic liver disease (included 13 patients with both HCV and alcoholic etiology of cirrhosis). SPT, standard psychometric tests; ICT, Inhibitory Control Test; NCT-A, Number Connection Test; DST, Digit Symbol Test; BDT, Block Design Test.

6 1596 BAJAJ ET AL GASTROENTEROLOGY Vol. 135, No. 5 Table 5. Test-Retest Reliability of ICT and SPT Performance Controls (n 20) Correlation coefficient OHE Development P value Cirrhotic patients (n 30) Correlation coefficient P value NCT-A (seconds) DST (raw score) BDT (raw score) Response to ICT lures Response to ICT targets NOTE. There was a significant correlation between the first and second administration of SPT components and ICT performance in controls and cirrhotic patients. SPT, standard psychometric tests; ICT, Inhibitory Control Test; NCT-A, Number Connection Test; DST, Digit Symbol Test; BDT, Block Design Test. All patients (apart from 15 who refused) were followed up for a mean of months since first enrollment for OHE development. Nineteen patients were diagnosed to have OHE; OHE was diagnosed 9 6 months after enrollment. Of the 19 patients, 6 developed OHE after acute variceal bleeding, 7 after infections requiring hospital admission, 3 after TIPS, and the remaining 3 diagnosed after undergoing an operation. All 19 patients had been diagnosed with MHE using both ICT and SPT. None of the 22 patients with discordant test results (11 who were positive for MHE using SPT but not ICT and 11 who were positive for MHE using ICT but not SPT) developed OHE on follow-up. There was no statistically significant difference in the SPT or ICT parameters of MHE patients who developed OHE compared with those who did not. External Validity Study Results Testing before and after TIPS. Fifteen consecutive patients undergoing elective TIPS placement within February 2007 and December 2007 were approached, of which 3 were on psychoactive medications and 2 refused to participate. The remaining 10 patients were initially tested 26 5 days prior to the TIPS placement. The patients underwent TIPS for refractory ascites (n 6), hepatic hydrothorax (n 2), and for control of chronic hemorrhage from rectal and stomal varices (n 2). Covered TIPS (Viatorr stent, Flagstaff, AZ) placement was successful in all patients, and a mean hepatic portal venous pressure gradient reduction of mm Hg post-tips was achieved. All were discharged home in a satisfactory condition. Three patients (2 underwent TIPS for refractory ascites and 1 for chronic bleeding) were noted to have developed OHE by clinical examination by their primary hepatologist. All 3 were started on lactulose and underwent the second visit testing while they were on lactulose treatment. The second visit with SPT and ICT testing occurred 35 8 days post-tips. There was a significant increase in lure response on the ICT post-tips with or without inclusion of the 3 post-tips OHE patients (Supplementary Figure 1; see Supplementary material online at www. gastrojournal.org and Table 6). ICT target response rate significantly worsened post-tips only when all patients were included. Similarly NCT-A performance was significantly affected only when all patients were considered. BDT and DST scores were impaired after TIPS placement, but this did not reach statistical significance (Table 6). Probiotic yogurt trial ICT results. Twenty-five patients were enrolled: 17 were randomized into the yogurt group and 8 into the no-treatment group. Three yogurt group patients did not complete the study (2 stopped it because of palatability issues, and 1 died of an unrelated Pseudomonas aeruginosa septicemia after spending time in a public hot tub). Two patients in the no-treatment group developed OHE in the 60-day study period. Therefore, 14 yogurt-assigned and 6 no-treatment-assigned patients completed the study. 22 There was significant improvement in psychometric test performance across all SPT tests in the yogurt group (Table 7). 22 Paralleling this was a statistically significant improvement in ICT lure and ICT target performance Table 6. Psychometric Performance Before and After Tips Before TIPS (n 10) Post-TIPS including OHE (n 10) Post-TIPS without OHE (n 7) Paired t test of pre- and post-tips patients (including OHE) (n 10) Paired t test of pre- and post-tips (excluding OHE) (n 7) NCT-A (seconds) DST (raw score) BDT (raw score) ICT lures ICT targets NOTE. Three patients developed OHE after TIPS and were tested while they were on lactulose therapy. There was a trend toward significant impairment of tests of the SPT after TIPS. ICT lure response rate increased and ICT target response rate decreased significantly after TIPS, indicating an impairment of ICT performance compared with before TIPS. TIPS, transvenous intrahepatic portosystemic shunting; SPT, standard psychometric tests; ICT, Inhibitory Control Test; NCT-A, Number Connection Test; DST, Digit Symbol Test; BDT, Block Design Test.

7 November 2008 DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY 1597 Table 7. Psychometric Performance Before and After Probiotic Yogurt in a Randomized Controlled Trial Yogurt baseline (n 17) No-Rx baseline (n 8) Yogurt end (n 14) No-Rx end (n 6) Yogurt within group, P values No-Rx within group, P values NCT-A (seconds) DST (raw score) BDT (raw score) ICT lures ICT targets NOTE. Probiotic yogurt therapy resulted in significant improvement in psychometric function in all SPT components in the probiotic yogurtrandomized group only. Similarly there was a significant improvement in ICT performance (increased ICT lure response and decreased ICT target response rates). There was no significant change in SPT or ICT in the no-treatment randomized group. No-Rx, no treatment; SPT, standard psychometric tests; ICT, Inhibitory Control Test; NCT-A, Number Connection Test; DST, Digit Symbol Test; BDT, Block Design Test. within the yogurt group (Supplementary Figure 2; see Supplementary material online at org). In contrast, there was no improvement in SPT or ICT parameters within the no-treatment group. 22 Time and Cost Analysis of ICT Administration in the Clinic The average time required for the medical assistants to administer the ICT in the clinic was 14 3 minutes compared with 32 7 minutes for SPT administration by a trained psychologist. Medicare reimbursement for more than 30 and less than 60 minutes of a psychologist s time to administer the SPT is $112, and the third-party billing charge is $348. In contrast, for ICT, an MA s time would cost $18 for Medicare and $41 for third-party insurance. The Institutional Review Board at the Medical College of Wisconsin approved this protocol. Discussion The current study demonstrates that the ICT is simple to administer and has a high sensitivity, area under the curve for diagnosis, and test-retest reliability for the diagnosis of MHE compared with SPT. ICT has external validity for MHE because it predicts OHE development, improves after successful MHE therapy, and worsens after TIPS placement. This study also demonstrates that ICT can be administered in clinics by MAs after a single training session, which makes ICT a less expensive method for MHE diagnosis than SPT. ICT measures response inhibition and attention, 2 basic cognitive domains that are affected in MHE. 24 The outcomes of ICT (lures, targets, and reaction times) provide measures of separate but complementary aspects of impairment in MHE. Lure response is an act of commission, signifying a defect in response inhibition. 18 Response inhibition is an essential aspect of executive function in the brain, which controls an individual s ability to inhibit a response that is perhaps prepotent but incorrect in a circumstance. 11,25 In the current study, all subjects were instructed to avoid responding to lures in the training session. Despite this, patients with MHE responded to a significantly higher number of lures compared with patients without MHE and healthy controls. Response inhibition underlies each action that is performed by the subject, and its impairment can be inherently responsible for potentiating wrong decisions in psychometric testing and in daily life, such as during driving. On the ICT, errors of omission produce a significantly lower target detection rate in MHE patients compared with controls and patients without MHE. These errors are considered primary errors of attention in that they represent a lapse in focus. Errors of omission along with longer lure and target reaction times are commonly associated with diminished processing speed and impairments in visuomotor function. 16 It is likely that MHE affects attention circuits that lead to functional impairments in these patients. 26 In addition, ICT lures response was also negatively correlated with ICT target performances, indicating that both these aspects of attention deficits coexist. Undoubtedly, the effects of these attention deficits on MHE patients performance in daily life are compounded when combined with impaired response inhibition. The standard battery used for the diagnosis for MHE in this study consists of 3 tests that evaluate the attention and visuomotor coordination. Previous studies have demonstrated a significantly worse performance of MHE patients on similar batteries and have recommended these tests for MHE diagnosis. 12 NCT-A or trail-making test involves connecting numbers from 1 to 25 accurately while being timed; it is a test of visual scanning speed, visual attention, and psychomotor tracking. DST, in which a subject has to transcribe nonsense symbols paired with numbers after referring to a key, is a test of mental speed and visuomotor coordination and memory. BDT is a test of visuospatial reasoning that requires spatial orientation, manipulation, and problem solving to rapidly reproduce designs shown to them using blocks. ICT impairment, for both lures and targets, were significantly correlated with impairment in NCT-A, DST, and BDT and also with the number of tests that were impaired. Because all SPT tests rely on accurate visual and attention processing, therefore, it is to be expected

8 1598 BAJAJ ET AL GASTROENTEROLOGY Vol. 135, No. 5 that the ICT, which is also a test of attention and processing speed, would correlate with performances on these tests. As shown in prior studies, performances on NCT-A, BDT, and DST significantly worsen with increasing age, a finding also demonstrated in our study. 9,27 To account for this, cirrhotic patients were matched on age to controls. In sharp contrast, ICT lure response rates do not significantly change with increasing age. This is an important distinction between SPT and ICT because the norms of SPT in most populations are age dependent, whereas ICT performance in controls and cirrhotic patients are not related to age. This potentially broadens and simplifies the applicability of ICT in the clinic setting. There are several confounding variables that can affect the diagnosis of MHE. Chronic hepatitis C infection has been proposed to result in neurocognitive deficits even before the development of cirrhosis. 28 In this study, there was no significant difference in SPT or ICT parameters patients with or without chronic hepatitis C infection. This has been similar to our prior published experience with ICT and shows that, in our population, the effect of cirrhosis probably outweighs the effect of chronic hepatitis C infection. Similarly, there was no significant difference in the psychometric performance on SPT and ICT in patients with alcoholic vs nonalcoholic etiology of cirrhosis. This is important to establish because the initial ICT study specifically excluded those with alcoholic cirrhosis, even those with proven alcohol abstinence. These findings further increase the applicability of the ICT across a broad range of prevalent chronic liver diseases. Both inter-/intraobserver reliability and test-retest reliability are important components of the overall validation for a diagnostic test. ICT is a patient-administered instrument that has an automated, computerized analysis system. Therefore inter-/intraobserver reliability is not important. There was a high correlation of ICT lures and targets between repeated administrations, indicating excellent test-retest reliability. This is essential because psychometric performance is an end point of MHE trials, and differentiating between learning and therapeutic effect of an MHE intervention is important. 5,29 The good test-retest reliability of ICT lures would make it a good test for application in trials. This study also addressed the external validity of the ICT by evaluating the ability of ICT to predict OHE and define post-tips and post-mhe therapy alterations in psychometric performance. Patients with MHE have a significantly higher rate of developing OHE, the detection of which is part of routine care. 4 Sixteen percent of included patients developed OHE in this study. Extending our previous experience with ICT, all OHE patients had been diagnosed with MHE using both ICT and SPT. 19 However, there was no significant difference in ICT lures or SPT individual performance between the patients who develop OHE and those who did not. TIPS is an excellent model for testing external validity of ICT because it can adversely affect psychometric function It has been hypothesized that patients with TIPS have a combination of portal hypoperfusion and increased availability of nitrogenous compounds because of the shunting. This results in worsening psychometric function and possibly OHE in 5% 35% of patients. 32,33 In this study, there was a significant worsening of SPT performance 1 month after TIPS placement compared with the pre-tips performance. Importantly, ICT lures worsened after TIPS placement in all but 1 patient. When the 3 patients without OHE after TIPS were excluded, ICT lures were the only psychometric test that was significantly impaired after TIPS placement. Although the number of patients was limited, this finding demonstrates that ICT performance worsens after TIPS. This is an important facet of external validity for ICT in patients with cirrhosis. Treatment for MHE is an attainable goal because gutbased therapy with lactulose, probiotics, and prebiotics has demonstrated improvement in psychometric functioning and quality of life. 34,35 Our group performed a randomized controlled trial of a probiotic yogurt vs no treatment in nonalcoholic cirrhotic patients over 60 days. 22 There was a significant improvement in individual tests of SPT in the yogurt group but not in the notreatment group. Patients who were randomized to yogurt in parallel to SPT improvement also had improvement in ICT lure response rate. In the no-treatment group, similar to the SPT, ICT lure response did not change. 22 This finding further establishes the external validity of ICT as a test that changes with change in the clinical status. The AASLD survey highlighted that a simple test that can be administered by clinic personnel would increase the chances of MHE testing in clinic. 13 In the present study, 2 previously untrained MAs were trained to administer the ICT in the hepatology clinic, and the time required to administer the test was compared with the SPT. Both administration time and associated costs were much smaller for ICT than for SPT. In contrast to SPT, which requires an additional appointment with a psychology specialist, ICT can be administered in the clinic by MAs while patients await their appointment with the hepatologist. Because of the high sensitivity and ease of administration, ICT would be useful as a screening test in clinics, which will aid in the decision of whether to treat or to send the patient for further testing. A modified version of the ICT will be made freely available to be downloaded after the trial has been published, which can increase the availability of MHE testing. In addition, because ICT involves recognizing specific letters, it can potentially be administered to non-english-speaking subjects with minimal modifications.

9 November 2008 DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY 1599 This study has several limitations. The educational status of the cirrhotic patients is high compared with the general population; however, despite this, cirrhotic patients as a whole and MHE patients in particular performed significantly worse on ICT and SPT compared with education-matched controls. Similar to our previous experience, most cirrhotic patients were Child Pugh class A or B. This is probably due to the high likelihood of Child Pugh class C patients being on OHE therapy, which was an exclusion criterion for this study. There is no current gold standard for MHE diagnosis, and this study used a modification of a recommended SPT battery; however, this study as well as our prior experience has found this method of MHE diagnosis to successfully predict OHE and driving impairment. 19,21 In addition, there was a good correlation between the number of impaired SPT and ICT results. The sample size for the TIPS and yogurt trial aspect were limited, but they did demonstrate a significant change in ICT that was similar to the change in SPT that was expected after TIPS and therapy. In summary, ICT is a sensitive test for the diagnosis of MHE, which can also predict OHE similar to SPT and has good external validity and test-retest reliability. ICT can be administered by clinic personnel without the need for psychologic expertise, which makes it an inexpensive option for MHE diagnosis. Supplementary Data Note: To access the supplementary material accompanying this article, visit the online version of Gastroenterology at and at doi: /j.gastro References 1. Mullen K, Ferenci P, Bass NM, et al. An algorithm for the management of hepatic encephalopathy. Semin Liv Dis 2007; 27: Li YY, Nie YQ, Sha WH, et al. Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World J Gastroenterol 2004;10: Das A, Dhiman RK, Saraswat VA, et al. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001;16: Romero-Gomez M, Boza F, Garcia-Valdecasas MS, et al. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001;96: Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007;45: Wein C, Koch H, Popp B, et al. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004;39: Bajaj JS, Hafeezullah M, Hoffmann RG, et al. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007;102: Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28: Weissenborn K, Ennen JC, Schomerus H, et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: Ford JM, Gray M, Whitfield SL, et al. Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging. Arch Gen Psychiatry 2004;61: Schiff S, Vallesi A, Mapelli D, et al. Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: a behavioral and electrophysiological study. Metab Brain Dis 2005;20: Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, Hepatology 2002;35: Bajaj JS, Etemadian A, Hafeezullah M, et al. Testing for minimal hepatic encephalopathy in the United States: an AASLD survey. Hepatology 2007;45: Epstein JN, Johnson DE, Varia IM, et al. Neuropsychological assessment of response inhibition in adults with ADHD. J Clin Exp Neuropsychol 2001;23: Konrad K, Gauggel S, Manz A, et al. Inhibitory control in children with traumatic brain injury (TBI) and children with attention deficit/ hyperactivity disorder (ADHD). Brain Inj 2000;14: Garavan H, Ross TJ, Stein EA. Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci U S A 1999;96: Pliszka SR, Liotti M, Woldorff MG. Inhibitory control in children with attention-deficit/hyperactivity disorder: event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. Biol Psychiatry 2000;48: Ballard JC. Assessing attention: comparison of response-inhibition and traditional continuous performance tests. J Clin Exp Neuropsychol 2001;23: Bajaj JS, Saeian K, Verber MD, et al. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 2007;102: Wechsler D. Wechsler Adult Intelligence Scale-III. San Antonio, TX; Psychological Corp, Bajaj JS, Hafeezullah M, Hoffmann RG, et al. Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008;47: Bajaj JS, Saeian K, Christensen K, et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008;103: AMA. Current Procedural Terminology. Chicago, IL; American Medical Association, Weissenborn K, Giewekemeyer K, Heidenreich S, et al. Attention, memory, and cognitive function in hepatic encephalopathy. Metab Brain Dis 2005;20: Walker AJ, Shores EA, Trollor JN, et al. Neuropsychological functioning of adults with attention deficit hyperactivity disorder. J Clin Exp Neuropsychol 2000;22: Ortiz M, Cordoba J, Jacas C, et al. Neuropsychological abnormalities in cirrhosis include learning impairment. J Hepatol 2006; 44: Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005;42(Suppl):S45 S Perry W, Hilsabeck RC, Hassanein TI. Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci 2008;53:

10 1600 BAJAJ ET AL GASTROENTEROLOGY Vol. 135, No Watanabe A, Sakai T, Sato S, et al. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 1997;26: Sanyal AJ, Freedman AM, Shiffman ML, et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994;20: Jalan R, Elton RA, Redhead DN, et al. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1995;23: Riggio O, Masini A, Efrati C, et al. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol 2005;42: Mullen KD, Ghanta RK, Putka BS. Prevention of first overt episode of hepatic encephalopathy after TIPS: no easy task. Hepatology 2006;43: Liu Q, Duan ZP, Ha da K, et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004;39: Malaguarnera M, Greco F, Barone G, et al. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebocontrolled study. Dig Dis Sci 2007;52: Received April 8, Accepted July 17, Address requests for reprints to: Jasmohan S Bajaj, MD, MS, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, 1201 Broad Rock Blvd, Richmond, VA. jasmohan.bajaj@va.gov; fax: (804) Supported in part by GCRC grant number M01-RR00058 and by the New Investigator Research Affairs Committee grant at the Medical College of Wisconsin (to J.S.B.). The authors disclose no conflicts.

11 November 2008 DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY 1600.e1 Supplementary Figure 1. Lure response rate before and after TIPS placement showed a significant worsening in lure response rate after TIPS placement. Three patients developed OHE and were re-tested while they were on lactulose. Total number of lures is 40. Supplementary Figure 2. There was a significant improvement in ICT lures after probiotic yogurt supplementation in a randomized controlled trial. The patients randomized to the no-treatment group did not show any significant difference in lure response rate before and after the trial. Solid lines indicate patients randomized to probiotic yogurt and dotted lines were patients randomized to the no-treatment group.

Patients With Minimal Hepatic Encephalopathy Have Poor Insight Into Their Driving Skills

Patients With Minimal Hepatic Encephalopathy Have Poor Insight Into Their Driving Skills CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6:1135 1139 Patients With Minimal Hepatic Encephalopathy Have Poor Insight Into Their Driving Skills JASMOHAN S. BAJAJ,* KIA SAEIAN, MUHAMMAD HAFEEZULLAH,

More information

The Importance of Diagnosing Covert Hepatic Encephalopathy

The Importance of Diagnosing Covert Hepatic Encephalopathy The Importance of Diagnosing Covert Hepatic Encephalopathy Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council

More information

A Simplified Psychometric Evaluation for the Diagnosis of Minimal Hepatic Encephalopathy

A Simplified Psychometric Evaluation for the Diagnosis of Minimal Hepatic Encephalopathy CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2011;9:613 616 A Simplified Psychometric Evaluation for the Diagnosis of Minimal Hepatic Encephalopathy OLIVIERO RIGGIO,* LORENZO RIDOLA,* CHIARA PASQUALE,* ILARIA

More information

Minimal and overt hepatic encephalopathy are constituents

Minimal and overt hepatic encephalopathy are constituents GASTROENTEROLOGY 2010;138:2332 2340 Persistence of Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy JASMOHAN S. BAJAJ,*, CHRISTINE M. SCHUBERT, DOUGLAS M. HEUMAN,* JAMES B. WADE, DOUGLAS

More information

Thank you. for supporting this program. For additional CME offerings, please visit

Thank you. for supporting this program. For additional CME offerings, please visit Thank you for supporting this program For additional CME offerings, please visit www.chronicliverdisease.org Accredited by: Disease Burden Patient Discharges with Cirrhosis* Hospital Discharges Associated

More information

Analysis of combined effect of synbiotic and LOLA in improving neuropsychometric function

Analysis of combined effect of synbiotic and LOLA in improving neuropsychometric function 2017; 6(5): 152-156 ISSN (E): 2277-7695 ISSN (P): 2349-8242 NAAS Rating 2017: 5.03 TPI 2017; 6(5): 152-156 2017 TPI www.thepharmajournal.com Received: 26-03-2017 Accepted: 27-04-2017 Preetha Nandabalan

More information

Cirrhosis and chronic liver disease adversely affect

Cirrhosis and chronic liver disease adversely affect Spectrum of Neurocognitive Impairment in Cirrhosis: Implications for the Assessment of Hepatic Encephalopathy Jasmohan S. Bajaj, 1 James B. Wade, 2 and Arun J. Sanyal 1 Abbreviations: BDT, Block Design

More information

Treatment of Overt Hepatic Encephalopathy: Focus on Outpatient Management

Treatment of Overt Hepatic Encephalopathy: Focus on Outpatient Management Treatment of Overt Hepatic Encephalopathy: Focus on Outpatient Management Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation

More information

Electroencephalography Versus Psychometric Tests in Diagnosis of Minimal Hepatic Encephalopathy

Electroencephalography Versus Psychometric Tests in Diagnosis of Minimal Hepatic Encephalopathy Elmer ress Original Article J Neurol Res. 2016;6(4):65-71 Electroencephalography Versus Psychometric Tests in Diagnosis of Minimal Hepatic Encephalopathy Aktham Ismail Alemam a, b, Mohamed Ahmad Shaaban

More information

The usefulness of critical flicker frequency in the diagnosis and follow-up of covert hepatic encephalopathy treated with Rifaximin-α

The usefulness of critical flicker frequency in the diagnosis and follow-up of covert hepatic encephalopathy treated with Rifaximin-α Human & Veterinary Medicine International Journal of the Bioflux Society OPEN ACCESS Research Article The usefulness of critical flicker frequency in the diagnosis and follow-up of covert hepatic encephalopathy

More information

Hepatic encephalopathy (HE) is a frequent and severe. Improving the Inhibitory Control Task to Detect Minimal Hepatic Encephalopathy

Hepatic encephalopathy (HE) is a frequent and severe. Improving the Inhibitory Control Task to Detect Minimal Hepatic Encephalopathy GASTROENTEROLOGY 2010;139:510 518 Improving the Inhibitory Control Task to Detect Minimal Hepatic Encephalopathy PIERO AMODIO,* LORENZO RIDOLA, SAMI SCHIFF,*, SARA MONTAGNESE,* CHIARA PASQUALE, SILVIA

More information

Prevalence of minimal hepatic encephalopathy in cirrhotic patients

Prevalence of minimal hepatic encephalopathy in cirrhotic patients S40 MODULE? Vol. 10 Suppl.2, 2011: S40-S44 Prevalence of minimal hepatic encephalopathy in cirrhotic patients Héctor Jesús Maldonado-Garza,* Genaro Vázquez-Elizondo,* Juan Obed Gaytán-Torres,* Ángel Ricardo

More information

Nutrition Management of End- Stage Liver Failure

Nutrition Management of End- Stage Liver Failure Nutrition Management of End- Stage Liver Failure Krystel Ouaijan, RDN, MSc Nutrition Support Dietitian in Saint George Hospital UMC PhD in University of Geneva Just few questions https://www.mentimeter.com/s/c1c1be18dc2

More information

Normalization of the Psychometric Hepatic Encephalopathy score for Diagnosis of Minimal Hepatic Encephalopathy in Turkey

Normalization of the Psychometric Hepatic Encephalopathy score for Diagnosis of Minimal Hepatic Encephalopathy in Turkey Original Article Normalization of the Psychometric Hepatic Encephalopathy score for Diagnosis of Minimal Hepatic Encephalopathy in Turkey BDO Coskun, M Ozen 1, S Gursoy 2, O Ozbakir 2, OK Poyrazoglu, M

More information

Transjugular intrahepatic portosystemic shunts

Transjugular intrahepatic portosystemic shunts Pre-Transjugular Intrahepatic Portosystemic Shunts (TIPS) Prediction of Post-TIPS Overt Hepatic Encephalopathy: The Critical Flicker Frequency Is More Accurate Than Psychometric Tests Pierre Berlioux,

More information

Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12:

Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12: Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12: 805-809. CLINICAL PEARL Indications for Use of TIPS in Treating Portal Hypertension Elizabeth C. Verna,

More information

Causes of Liver Disease in US

Causes of Liver Disease in US Learning Objectives Updates in Outpatient Cirrhosis Management Jennifer Guy, MD MAS Director, Liver Cancer Program California Pacific Medical Center guyj@sutterhealth.org Review cirrhosis epidemiology,

More information

Hepatic Encephalopathy Update: Reports from the 64th Annual Meeting of the American Association for the Study of Liver Diseases

Hepatic Encephalopathy Update: Reports from the 64th Annual Meeting of the American Association for the Study of Liver Diseases Hepatic Encephalopathy Update: Reports from the 64th Annual Meeting of the American Association for the Study of Liver Diseases Credit Designation Purdue University College of Pharmacy designates this

More information

Program Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals.

Program Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals. Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship

More information

Managing Encephalopathy in the Outpatient Setting

Managing Encephalopathy in the Outpatient Setting REVIEW Managing Encephalopathy in the Outpatient Setting Sahaj Rathi, M.D., and Radha K. Dhiman, M.D., D.M., F.A.M.S., F.A.C.G., F.R.C.P., F.A.A.S.L.D. Hepatic encephalopathy (HE) refers to brain dysfunction

More information

Minimal Hepatic Encephalopathy in Cirrhosis- How Long to Treat?

Minimal Hepatic Encephalopathy in Cirrhosis- How Long to Treat? Minimal hepatic encephalopathy in cirrhosis., 2017; 16 (1): 115-122 ORIGINAL ARTICLE January-February, Vol. 16 No. 1, 2017: 115-122 115 The Official Journal of the Mexican Association of Hepatology, the

More information

The Chronic Liver Disease Foundation (CLDF) and the International Coalition of Hepatology Education Providers (IC-HEP) present:

The Chronic Liver Disease Foundation (CLDF) and the International Coalition of Hepatology Education Providers (IC-HEP) present: The Chronic Liver Disease Foundation (CLDF) and the International Coalition of Hepatology Education Providers (IC-HEP) present: Certified by: Provided by: Endorsed by: Hepatic Encephalopathy Hepatic Encephalopathy:

More information

Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis

Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis Turk J Gastroenterol 2017; 28: 191-6 Liver Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis Banu Demet Özel Coşkun 1, Mustafa Özen 2 1 Clinic of

More information

Management of Cirrhosis Related Complications

Management of Cirrhosis Related Complications Management of Cirrhosis Related Complications Ke-Qin Hu, MD, FAASLD Professor of Clinical Medicine Director of Hepatology University of California, Irvine Disclosure I have no disclosure related to this

More information

Hepatic Encephalopathy Update: Reports from the 2013 International Liver Conference

Hepatic Encephalopathy Update: Reports from the 2013 International Liver Conference Reports from the 2013 International Liver Conference Credit Designation Purdue University College of Pharmacy designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians

More information

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES International Journal of Institutional Pharmacy and Life Sciences 5(5): September-October 2015 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Life Sciences Research Article!!! Received:

More information

Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis Ming Luo a, Lei Li a, Chen-Zheng Lu b and Wu-Kui Cao c

Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis Ming Luo a, Lei Li a, Chen-Zheng Lu b and Wu-Kui Cao c 1250 Original article Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis Ming Luo a, Lei Li a, Chen-Zheng Lu b and Wu-Kui Cao c Objective To evaluate the clinical

More information

Format for Manuscript Submission: Field of Vision

Format for Manuscript Submission: Field of Vision Format for Manuscript Submission: Field of Vision Name of Journal: World Journal of Gastroenterology Manuscript Type: FIELD OF VISION Motor vehicle accidents: How should cirrhotic patients be managed?

More information

Hepatic Encephalopathy Update:

Hepatic Encephalopathy Update: Hepatic Encephalopathy Update: Reports From the American Association for the Study of Liver Diseases Annual Meeting, 2011 Project ID: 11-0014-NL-4 Credit Designation Hepatic encephalopathy (HE) is a largely

More information

Contraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for:

Contraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for: Contraindications Absolute Relative Primary prevention variceal bleeding HCC if centrally located Active congestive heart failure Obstruction all hepatic veins Thomas D. Boyer, M.D. University of Arizona

More information

What s New in the Management of Hepatic Encephalopathy?

What s New in the Management of Hepatic Encephalopathy? What s New in the Management of Hepatic Encephalopathy? Jasmohan S Bajaj, MD Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond,

More information

Rapidly-administered short forms of the Wechsler Adult Intelligence Scale 3rd edition

Rapidly-administered short forms of the Wechsler Adult Intelligence Scale 3rd edition Archives of Clinical Neuropsychology 22 (2007) 917 924 Abstract Rapidly-administered short forms of the Wechsler Adult Intelligence Scale 3rd edition Alison J. Donnell a, Neil Pliskin a, James Holdnack

More information

The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies

The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies INVITED REVIEW Annals of Gastroenterology (2018) 31, 1-14 The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies Lorenzo Ridola a, Vincenzo Cardinale a, Oliviero Riggio

More information

Transjugular Intrahepatic Portosystemic Shunt Reduction for Management of Recurrent Hepatic Encephalopathy

Transjugular Intrahepatic Portosystemic Shunt Reduction for Management of Recurrent Hepatic Encephalopathy CLINICAL IMAGES Ochsner Journal 17:311 316, 2017 Ó Academic Division of Ochsner Clinic Foundation Transjugular Intrahepatic Portosystemic Shunt Reduction for Management of Recurrent Hepatic Encephalopathy

More information

In-Hospital Mortality and Economic Burden Associated With Hepatic Encephalopathy in the United States From 2005 to 2009

In-Hospital Mortality and Economic Burden Associated With Hepatic Encephalopathy in the United States From 2005 to 2009 CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:1034 1041 In-Hospital Mortality and Economic Burden Associated With Hepatic Encephalopathy in the United States From 2005 to 2009 MARIA STEPANOVA, ALITA

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Sun LS, Li G, Miller TLK, et al. Association between a single general anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood. JAMA. doi:10.1001/jama.2016.6967

More information

MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy

MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy Martel-Laferrière et al. BMC Gastroenterology 2014, 14:185 RESEARCH ARTICLE Open Access MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy

More information

Program Disclosure. A maximum of 1.5 contact hours may be earned for successful completion of this activity.

Program Disclosure. A maximum of 1.5 contact hours may be earned for successful completion of this activity. Program Disclosure This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through

More information

Preliminary study of the permeability and safety of covered stents-grafts in pediatric TIPS

Preliminary study of the permeability and safety of covered stents-grafts in pediatric TIPS Preliminary study of the permeability and safety of covered stents-grafts in pediatric TIPS Poster No.: C-0354 Congress: ECR 2013 Type: Scientific Exhibit Authors: A. Bueno Palomino, L. Zurera Tendero,

More information

The University Hospitals and Clinics The University of Mississippi Medical Center Jackson, Mississippi

The University Hospitals and Clinics The University of Mississippi Medical Center Jackson, Mississippi The University Hospitals and Clinics The University of Mississippi Medical Center Jackson, Mississippi Pharmacy and Therapeutics Committee Drug Evaluation (Xifaxan ) June 2012 Generic Name Brand Name Xifaxan

More information

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT Sherona Bau, ACNP The Pfleger Liver Institute 200 UCLA Medical Plaza, Suite 214 Los Angeles, CA 90095 September 30, 2017 I

More information

Improving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan

Improving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan Improving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan Grant L. Iverson, Ph.D, Professor Department of Physical Medicine and Rehabilitation Harvard Medical School & Red Sox

More information

Carvedilol or Propranolol in the Management of Portal Hypertension?

Carvedilol or Propranolol in the Management of Portal Hypertension? Evidence Based Case Report Carvedilol or Propranolol in the Management of Portal Hypertension? Arranged by: dr. Saskia Aziza Nursyirwan RESIDENCY PROGRAM OF INTERNAL MEDICINE DEPARTMENT UNIVERSITY OF INDONESIA

More information

V ariceal haemorrhage is a major cause of mortality and

V ariceal haemorrhage is a major cause of mortality and 270 LIVER DISEASE The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric : clinical and haemodynamic correlations D Tripathi, G Therapondos, E

More information

Esophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph

Esophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph Esophageal Varices Beta-Blockers or Band Ligation Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph Esophageal Varices Beta-Blockers or Band Ligation? Risk of esophageal variceal

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,100 116,000 120M Open access books available International authors and editors Downloads Our

More information

Management of Hepatic Encephalopathy

Management of Hepatic Encephalopathy Management of Hepatic Encephalopathy Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Disclosure 1. The speaker Atif Zaman, MD MPH

More information

Cognitive abnormalities in cirrhosis

Cognitive abnormalities in cirrhosis AISF 2015 - Young Investigator Lecture Cognitive abnormalities in cirrhosis Sara Montagnese Disclosures I have received lecture fees from Merz Pharmaceuticals GmbH and Norgine The University of Padova

More information

This educational website is funded by a grant from Norgine. Norgine has no responsibility for content or conduct of this website.

This educational website is funded by a grant from Norgine. Norgine has no responsibility for content or conduct of this website. Date of preparation: February 2014. 4C/NIPV/0517 1 This educational website is funded by a grant from Norgine. Norgine has no responsibility for content or conduct of this website. 2 Disclaimer This educational

More information

Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate

Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate Patrick Northup, MD, FAASLD, FACG Medical Director, Liver Transplantation University of Virginia

More information

ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT

ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2010;8:703 708 ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT Compliance With Practice Guidelines and Risk of a First Esophageal Variceal Hemorrhage in Patients

More information

ENCORE-PH Top-line Results

ENCORE-PH Top-line Results ENCORE-PH Top-line Results Striving to improve human health December 5, 2018 NASDAQ CNAT Forward-looking Statements This presentation contains forward-looking statements. All statements other than statements

More information

European. Young Hepatologists Workshop. Organized by : Quantification of fibrosis and cirrhosis outcomes

European. Young Hepatologists Workshop. Organized by : Quantification of fibrosis and cirrhosis outcomes supported by from Gilea Quantification of fibrosis and cirrhosis outcomes th 5 European 5 European Young Hepatologists Workshop Young Hepatologists Workshop August, 27-29. 2015, Moulin de Vernègues Vincenza

More information

Organ allocation for liver transplantation: Is MELD the answer? North American experience

Organ allocation for liver transplantation: Is MELD the answer? North American experience Organ allocation for liver transplantation: Is MELD the answer? North American experience Douglas M. Heuman, MD Virginia Commonwealth University Richmond, VA, USA March 1998: US Department of Health and

More information

NIH Public Access Author Manuscript Aliment Pharmacol Ther. Author manuscript; available in PMC 2014 April 01.

NIH Public Access Author Manuscript Aliment Pharmacol Ther. Author manuscript; available in PMC 2014 April 01. NIH Public Access Author Manuscript Published in final edited form as: Aliment Pharmacol Ther. 2011 April ; 33(7): 739 747. doi:10.1111/j.1365-2036.2011.04590.x. Review article: the design of clinical

More information

Evidence-Base Management of Esophageal and Gastric Varices

Evidence-Base Management of Esophageal and Gastric Varices Evidence-Base Management of Esophageal and Gastric Varices Rino Alvani Gani Hepatobiliary Division Department of Internal Medicine Faculty of Medicine Universitas Indonesia Cipto Mangunkusumo National

More information

The Management of Ascites & Hepatorenal Syndrome. Florence Wong University of Toronto. Falk Symposium March 14, 2008

The Management of Ascites & Hepatorenal Syndrome. Florence Wong University of Toronto. Falk Symposium March 14, 2008 The Management of Ascites & Hepatorenal Syndrome Florence Wong University of Toronto Falk Symposium March 14, 2008 Management of Ascites Sodium Restriction Mandatory at all stages of ascites in order to

More information

The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis

The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis Omar I. Massoud, MD, PhD, and Nizar N. Zein, MD Dr Massoud is an associate professor of medicine

More information

Chronic liver failure affects multiple organ systems and

Chronic liver failure affects multiple organ systems and ORIGINAL ARTICLES Model for End-Stage Liver Disease (MELD) Predicts Nontransplant Surgical Mortality in Patients With Cirrhosis Patrick G. Northup, MD,* Ryan C. Wanamaker, MD, Vanessa D. Lee, MD, Reid

More information

Test review. Comprehensive Trail Making Test (CTMT) By Cecil R. Reynolds. Austin, Texas: PRO-ED, Inc., Test description

Test review. Comprehensive Trail Making Test (CTMT) By Cecil R. Reynolds. Austin, Texas: PRO-ED, Inc., Test description Archives of Clinical Neuropsychology 19 (2004) 703 708 Test review Comprehensive Trail Making Test (CTMT) By Cecil R. Reynolds. Austin, Texas: PRO-ED, Inc., 2002 1. Test description The Trail Making Test

More information

Performance You Can See & Hear

Performance You Can See & Hear Performance You Can See & Hear Exclusively from A S S E S S M E N T S About the Performance Tests Evaluate attention disorders and neurological functioning with the Conners Continuous Performance Tests,

More information

CIRRHOSIS Definition

CIRRHOSIS Definition Cirrhosis Update Robert S. Brown, Jr., MD, MPH Vice Chair, Transitions of Care Interim Chief, Division of Gastroenterology & Hepatology Weill Cornell Medical College CIRRHOSIS Definition Irreversible fibrous

More information

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed?

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed? CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed? The Hospitalist. 2016 August;2016(8) Author(s): Raj Sehgal, MD; Joshua Hanson, MD, MPH; Division OF The

More information

Up to 70% of individuals with cirrhosis (regardless of

Up to 70% of individuals with cirrhosis (regardless of SCIENTIFIC INVESTIGATIONS Objectives: This study was conducted to assess the ill-defined relationship between sleep quality and multiple, specific domains of cognitive function in patients with cirrhosis.

More information

ACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis

ACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis ACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis Guadalupe Garcia-Tsao, M.D., 1 Arun J. Sanyal, M.D., 2 Norman D. Grace,

More information

Cuban Normality Tables for Psychometric Tests Used for Diagnosis of Minimal Hepatic Encephalopathy

Cuban Normality Tables for Psychometric Tests Used for Diagnosis of Minimal Hepatic Encephalopathy Original articles Cuban Normality Tables for Psychometric Tests Used for Diagnosis of Minimal Hepatic Encephalopathy Maykel Alain Padilla Ruiz, MD, MSc 1 1 First Degree Specialist in Gastroenterology,

More information

Hepatic encephalopathy (HE) is a serious and frequent complication

Hepatic encephalopathy (HE) is a serious and frequent complication Published December 11, 2014 as 10.3174/ajnr.A4146 ORIGINAL RESEARCH BRAIN Identification of Minimal Hepatic Encephalopathy in Patients with Cirrhosis Based on White Matter Imaging and Bayesian Data Mining

More information

Title: Cholestasis after TIPS placement in a patient with primary sclerosing cholangitis: an uncommon complication

Title: Cholestasis after TIPS placement in a patient with primary sclerosing cholangitis: an uncommon complication Title: Cholestasis after TIPS placement in a patient with primary sclerosing cholangitis: an uncommon complication Authors: Alejandro Salagre García, Carolina Muñoz Codoceo, Elena Gómez Domínguez, Inmaculada

More information

M P---- Ph.D. Clinical Psychologist / Neuropsychologist

M P---- Ph.D. Clinical Psychologist / Neuropsychologist M------- P---- Ph.D. Clinical Psychologist / Neuropsychologist NEUROPSYCHOLOGICAL EVALUATION Name: Date of Birth: Date of Evaluation: 05-28-2015 Tests Administered: Wechsler Adult Intelligence Scale Fourth

More information

Management of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy

Management of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy Management of Ascites and Hepatorenal Syndrome Florence Wong University of Toronto June 4, 2016 6/16/2016 1 Disclosures Gore & Associates: Consultancy Sequana Medical: Research Funding Mallinckrodt Pharmaceutical:

More information

Variceal bleeding. Mainz,

Variceal bleeding. Mainz, Variceal bleeding Mainz, 21.09.2008 Risk of complications 5 years 10 years Ascites 10 % 25 % HCC 10 % 25 % Bleeding < 5 % 5-10 % Enceph. < 5 % < 5 % Typical situation : Mortality 10 % to 40 % Sequence

More information

Embolization of Portosystemic Shunts for Treatment of Medically Refractory Hepatic Encephalopathy

Embolization of Portosystemic Shunts for Treatment of Medically Refractory Hepatic Encephalopathy ORIGINAL ARTICLE Embolization of Portosystemic Shunts for Treatment of Medically Refractory Hepatic Encephalopathy Amanda M. Lynn, 1 Siddharth Singh, 4 Stephen E. Congly, 5 Disha Khemani, 2 David H. Johnson,

More information

Primary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation

Primary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation Primary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation Siwaporn Chainuvati, MD Faculty of Medicine Siriraj Hospital Outline Natural history of esophageal varices Which

More information

Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients

Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients Oregon Health & Science University OHSU Digital Commons Scholar Archive 9-2014 Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients

More information

Interpreting change on the WAIS-III/WMS-III in clinical samples

Interpreting change on the WAIS-III/WMS-III in clinical samples Archives of Clinical Neuropsychology 16 (2001) 183±191 Interpreting change on the WAIS-III/WMS-III in clinical samples Grant L. Iverson* Department of Psychiatry, University of British Columbia, 2255 Wesbrook

More information

Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China

Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China Online Submissions: http://www.wjgnet.com/esps/ wjg@wjgnet.com doi:10.3748/wjg.v19.i30.4984 World J Gastroenterol 2013 August 14; 19(30): 4984-4991 ISSN 1007-9327 (print) ISSN 2219-2840 (online) 2013 Baishideng.

More information

Neuropsychological Testing (NPT)

Neuropsychological Testing (NPT) Neuropsychological Testing (NPT) POLICY Psychological testing (96101-03) refers to a series of tests used to evaluate and treat an individual with emotional, psychiatric, neuropsychiatric, personality

More information

The hepatitis C virus (HCV) is the most common cause of

The hepatitis C virus (HCV) is the most common cause of Neuropsychological Impairment in Patients With Chronic Hepatitis C Robin C. Hilsabeck, William Perry, and Tarek I. Hassanein Hepatitis C is the most common cause of chronic liver disease in the United

More information

Minimal Hepatic Encephalopathy

Minimal Hepatic Encephalopathy Review articles Crhistian Camilo Gómez D., 1 Juan Carlos Restrepo G., MD 2 1 Medical Student at the University of Antioquia in Medellín, Colombia 2 Unit of Hepatology and Liver Transplant Program of the

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACLF. See Acute-on-chronic liver failure (ACLF) Acute kidney injury (AKI) in ACLF patients, 967 Acute liver failure (ALF), 957 964 causes

More information

Evidence Analysis Library Research Project

Evidence Analysis Library Research Project Evidence Analysis Library Research Project EAL question: What is the evidence to support the use of supplementing BCAA in patients with cirrhosis to 1) prevent further liver damage or improve liver function;

More information

The Leeds Teaching Hospitals NHS Trust Transjugular Intrahepatic Portosystemic Shunt (TIPS)

The Leeds Teaching Hospitals NHS Trust Transjugular Intrahepatic Portosystemic Shunt (TIPS) n The Leeds Teaching Hospitals NHS Trust Transjugular Intrahepatic Portosystemic Shunt (TIPS) Information for patients Your liver doctor has recommended that you have a Transjugular Intrahepatic Portosystemic

More information

Diagnosis and Management of Hepatic Encephalopathy

Diagnosis and Management of Hepatic Encephalopathy Diagnosis and Management of Hepatic Encephalopathy Fred Poordad, MD VP, Academic and Clinical Affairs The Texas Liver Institute Professor of Medicine University of Texas Health Science Center San Antonio,

More information

Physician specialty and the outcomes and cost of admissions for end-stage liver disease Ko C W, Kelley K, Meyer K E

Physician specialty and the outcomes and cost of admissions for end-stage liver disease Ko C W, Kelley K, Meyer K E Physician specialty and the outcomes and cost of admissions for end-stage liver disease Ko C W, Kelley K, Meyer K E Record Status This is a critical abstract of an economic evaluation that meets the criteria

More information

Use of transjugular intrahepatic portosystemic shunt in liver disease

Use of transjugular intrahepatic portosystemic shunt in liver disease Vol. XVIII No. 3 JOURNAL OF VASCULAR NURSING PAGE 83 Use of transjugular intrahepatic portosystemic shunt in liver disease Patricia Ann Radovich, RN, MSN, CCRN, FCCM Persons with cirrhosis have many complications.

More information

February 8, Prepared By: Glen M. Doniger, PhD Director of Scientific Development NeuroTrax Corporation

February 8, Prepared By: Glen M. Doniger, PhD Director of Scientific Development NeuroTrax Corporation 1 February 8, 2007 Prepared By: Glen M. Doniger, PhD Director of Scientific Development 2...3...3...3...5...6...6...7!" #"...7 ""...8...9 $#%&#$%'#...11!...12 "# $...14!...15 %...18 3 In the following

More information

What Is the Real Gain After Liver Transplantation?

What Is the Real Gain After Liver Transplantation? LIVER TRANSPLANTATION 15:S1-S5, 9 AASLD/ILTS SYLLABUS What Is the Real Gain After Liver Transplantation? James Neuberger Organ Donation and Transplantation, NHS Blood and Transplant, Bristol, United Kingdom;

More information

THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME

THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME PERNECZKY 15/06/06 14:35 Page 1 THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME R. PERNECZKY, A. KURZ Department of Psychiatry and Psychotherapy, Technical University of Munich, Germany. Correspondence

More information

Hepatology For The Nonhepatologist

Hepatology For The Nonhepatologist Hepatology For The Nonhepatologist Andrew Aronsohn, MD Associate Professor of Medicine University of Chicago Chicago, Illinois Learning Objectives After attending this presentation, learners will be able

More information

Leigh C. Casadaban 1 Ahmad Parvinian 1 Patrick M. Couture 1 Jeet Minocha 2 M. Grace Knuttinen 2 James T. Bui 2 Ron C. Gaba 2

Leigh C. Casadaban 1 Ahmad Parvinian 1 Patrick M. Couture 1 Jeet Minocha 2 M. Grace Knuttinen 2 James T. Bui 2 Ron C. Gaba 2 Vascular and Interventional Radiology Original Research Casadaban et al. Hepatobiliary Laboratory Alterations After TIPS Vascular and Interventional Radiology Original Research Leigh C. Casadaban 1 Ahmad

More information

Impact of Chronic Liver Disease and Cirrhosis on Health Utilities Using SF-6D and the Health Utility Index

Impact of Chronic Liver Disease and Cirrhosis on Health Utilities Using SF-6D and the Health Utility Index LIVER TRANSPLANTATION 14:321-326, 2008 ORIGINAL ARTICLE Impact of Chronic Liver Disease and Cirrhosis on Health Utilities Using SF-6D and the Health Utility Index Amy A. Dan, 1,2 Jillian B. Kallman, 1,2

More information

Table 1: Summary of measures of cognitive fatigability operationalised in existing research.

Table 1: Summary of measures of cognitive fatigability operationalised in existing research. Table 1: Summary of measures of cognitive fatigability operationalised in existing research. Candidate Mmeasures Studies Procedure Self-reported fatigue measure Key Findings The auditory As and auditory

More information

DENISE M CULL M.Psych, (Forensic)

DENISE M CULL M.Psych, (Forensic) Recovery from Physical, Psychological and Cognitive Trauma using NeurOptimal Neurofeedback. A case study presenting pre- and post- neuropsychometric tests and SPECT Scan results. ABBREVIATED POWER POINT

More information

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 66/ Aug 17, 2015 Page 11478

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 66/ Aug 17, 2015 Page 11478 A STUDY OF THE CLINICAL PROFILE OF CIRRHOSIS OF LIVER AND ANALYSIS OF PRECIPITATING FACTORS IN HEPATIC ENCEPHALOPATHY Sai Lakshmi Bharathi 1, Vengadakrishnan K 2, Rajkumar M 3 HOW TO CITE THIS ARTICLE:

More information

King Abdul-Aziz University Hospital (KAUH) is a tertiary

King Abdul-Aziz University Hospital (KAUH) is a tertiary Modelling Factors Causing Mortality in Oesophageal Varices Patients in King Abdul Aziz University Hospital Sami Bahlas Abstract Objectives: The objective of this study is to reach a model defining factors

More information

Life After SVR for Cirrhotic HCV

Life After SVR for Cirrhotic HCV Life After SVR for Cirrhotic HCV KIM NEWNHAM MN, NP CIRRHOSIS CARE CLINIC UNIVERSITY OF ALBERTA Objectives To review the benefits of HCV clearance in cirrhotic patients To review some of the emerging data

More information

Copyright 2002 American Academy of Neurology. Volume 58(8) 23 April 2002 pp

Copyright 2002 American Academy of Neurology. Volume 58(8) 23 April 2002 pp Copyright 2002 American Academy of Neurology Volume 58(8) 23 April 2002 pp 1288-1290 Improved executive functioning following repetitive transcranial magnetic stimulation [Brief Communications] Moser,

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: rifaximin (Xifaxan) Reference Number: HIM.PA.68 Effective Date: 12/14 Last Review Date: 08/17 Line of Business: Health Insurance Marketplace Coding Implications Revision Log See Important

More information

Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis

Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis Sponsored by Integrity Continuing Education, Inc. Supported by an educational Practitioner

More information